Abstract
Abstract
Background and aim
In the past, increased latencies of the blue-on-yellow pattern visually evoked potentials (BY-VEP), which predominantly originate in the koniocellular pathway, have proven to be a sensitive biomarker for early glaucoma. However, a complex experimental setup based on an optical bench was necessary to obtain these measurements because computer screens lack sufficient temporal, spatial, spectral, and luminance resolution. Here, we evaluated the diagnostic value of a novel setup based on a commercially available video projector.
Methods
BY-VEPs were recorded in 126 participants (42 healthy control participants, 12 patients with ocular hypertension, 17 with “preperimetric” glaucoma, and 55 with perimetric glaucoma). Stimuli were created with a video projector (DLP technology) by rear projection of a blue checkerboard pattern (460 nm) for 200 ms (onset) superimposed on a bright yellow background (574 nm), followed by an offset interval where only the background was active. Thus, predominantly S-cones were stimulated while L- and M-cone responses were suppressed by light adaptation. Times of stimulus onset to VEP onset-trough (N-peak time) and offset-peak (P-peak time) were analyzed after age-correction based on linear regression in the normal participants.
Results
The resulting BY-VEPs were quite similar to those obtained in the past with the optical bench: pattern-onset generated a negative deflection of the VEP, whereas the offset-response was dominated by a positive component. N-peak times were significantly increased in glaucoma patients (preperimetric 136.1 ± 10 ms, p < 0.05; perimetric 153.1 ± 17.8 ms, p < 0.001) compared with normal participants (123.6 ± 7.7 ms). Furthermore, they were significantly correlated with disease severity as determined by visual field losses retinal nerve fiber thinning (Spearman R = –0.7, p < 0.001).
Conclusions
Video projectors can be used to create optical stimuli with high temporal and spatial resolution, thus potentially enabling sophisticated electrophysiological measurements in clinical practice. BY-VEPs based on such a projector had a high diagnostic value for detection of early glaucoma.
Registration of study
Registration site: www.clinicaltrials.gov
Trial registration number: NCT00494923.
Funder
Universitätsklinikum Erlangen
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference44 articles.
1. Greenstein VC, Seliger S, Zemon V, Ritch R (1998) Visual evoked potential assessment of the effects of glaucoma on visual subsystems. Vision Res 38:1901–1911
2. Hu CX, Zangalli C, Hsieh M, Gupta L, Williams AL, Richman J, Spaeth GL (2014) What do patients with glaucoma see? Visual symptoms reported by patients with glaucoma. Am J Med Sci 348:403–409. https://doi.org/10.1097/maj.0000000000000319
3. Horn FK, Jonas JB, Budde WM, Jünemann AM, Mardin CY, Korth M (2002) Monitoring glaucoma progression with visual evoked potentials of the blue-sensitive pathway. Invest Ophthalmol Vis Sci 43:1828–1834
4. Anderson RS (2006) The psychophysics of glaucoma: improving the structure/function relationship. Elsevier Ltd 25:79–97. https://doi.org/10.1016/j.preteyeres.2005.06.001
5. Tai TYT (2018) Visual evoked potentials and glaucoma. Asia Pac J Ophthalmol (Phila) 7:352–355. https://doi.org/10.22608/APO.2017532
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献